S3E4 - Kelli A. Boyden, JD; MS Pharmaceutical Sciences (Regulation) (2024) | Post-Scrip: The ASPL Pharmacy Law Podcast
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
S3E4 - Kelli A. Boyden, JD; MS Pharmaceutical Sciences (Regulation) (2024) | Post-Scrip: The ASPL Pharmacy Law Podcast
-
Narrado por:
-
De:
Acerca de esta escucha
In this episode of Post-Scrip, Henry introduces Kelli A. Boyden, JD; MS Pharmaceutical Sciences (Regulation) (2024). They discuss the upcoming "Key Supreme Court Decisions Impacting Pharmacies".
This presentation will focus on The U.S. Supreme Court’s rulings this year carry real-world effects on the pharmacy industry, including the FDA’s approval of mifepristone and addressing the standard for how courts defer to agencies. We will review these key Supreme Court’s decisions and discuss what the outcomes mean to pharmacy lawyers.
The Supreme Court’s review of the FDA’s approval of mifepristone in FDA v. Alliance for Hippocratic Medicine will shed light on future legal challenges to FDA approvals and resolve one issue in the evolving landscape for pharmacies with respect to dispensing medication abortion drugs.
Join us at the 35th annual conference: Developments in Pharmacy Law Seminar , November 7-10, 2024 in Phoenix, Arizona